In a study identifying therapeutic response and survival biomarkers, longitudinal changes in HGF serum levels following chemoradiation in patients with advanced HNSCC were found to significantly correlate with increased relative risk of death upon adjustment for smoking status [85]. The gene discussed is HGF; the disease is head and neck squamous cell carcinoma.